发明名称 THERAPEUTIC AGENT FOR DIABETES
摘要 PROBLEM TO BE SOLVED: To provide a therapeutic agent for diabetes which comprises a 2-(N- cyanoimino)thiazolidin-4-one derivative, or its solvate or pharmaceutically permissive salt as an active component. SOLUTION: This 2-(N-cyanoimino)thiazolidin-4-one derivative represented by general formula (1) [wherein A ring is benzene ring, a condensed ring or a heterocycle all of which may be substituted with a linear of branched 1-4C alkyl group, an alkyl halide group or the like; R is a single bond, O, S, methine, a linear or branched 1-4C alkylene group which may be substituted with phenyl group, or the like; R2 and R3 are each H, a 1-4C alkyl group or the like; R4 is H or a 1-4C alkyl group; and the substitution site of methylene group at 5 position in thiazolidine shows both of E and Z] has excellent therapeutic action on diabetes and also has ameliorating action on hyperlipemia such as hypertriglyceridemia.
申请公布号 JP2001199888(A) 申请公布日期 2001.07.24
申请号 JP20000014970 申请日期 2000.01.24
申请人 FUJIMOTO BROTHERS:KK 发明人 YONEDA FUMIO;MURAOKA SHIZUKO;OIDE HIROISA;WATABE MAYUMI;TOBU KAZUNORI;TAKEUCHI IKUKO
分类号 A61K31/426;A61K31/427;A61K31/428;A61K31/4439;A61P3/06;A61P3/10;A61P43/00;C07D277/20;C07D277/38;C07D277/40;C07D277/42;C07D277/64;C07D277/74;C07D417/10;C07D417/12;(IPC1-7):A61K31/426;A61K31/443 主分类号 A61K31/426
代理机构 代理人
主权项
地址